Risk factors for proliferative vitreoretinopathy after retinal detachment surgery: A systematic review and meta-analysis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
02
04
2023
accepted:
26
09
2023
medline:
1
11
2023
pubmed:
30
10
2023
entrez:
30
10
2023
Statut:
epublish
Résumé
To comprehensively investigate risk factors for proliferative vitreoretinopathy (PVR) after retinal detachment (RD) surgery. PubMed, Embase, Cochrane Library, and Web of Science were systematically searched until May 22, 2023. Risk factors included demographic and disease-related risk factors. Odds ratios (ORs) and weighted mean differences (WMDs) were used as the effect sizes, and shown with 95% confidence intervals (CIs). Sensitivity analysis was conducted. The protocol was registered with PROSPERO (CRD42022378652). Twenty-two studies of 13,875 subjects were included in this systematic review and meta-analysis. Increased age was associated with a higher risk of postoperative PVR (pooled WMD = 3.98, 95%CI: 0.21, 7.75, P = 0.038). Smokers had a higher risk of postoperative PVR than non-smokers (pooled OR = 5.07, 95%CI: 2.21-11.61, P<0.001). Presence of preoperative PVR was associated with a greater risk of postoperative PVR (pooled OR = 22.28, 95%CI: 2.54, 195.31, P = 0.005). Presence of vitreous hemorrhage was associated with a greater risk of postoperative PVR (pooled OR = 4.12, 95%CI: 1.62, 10.50, P = 0.003). Individuals with aphakia or pseudophakia had an increased risk of postoperative PVR in contrast to those without (pooled OR = 1.41, 95%CI: 1.02, 1.95, P = 0.040). The risk of postoperative PVR was higher among patients with macula off versus those with macula on (pooled OR = 1.85, 95%CI: 1.24, 2.74, P = 0.002). Extent of RD in patients with postoperative PVR was larger than that in patients without (pooled WMD = 0.31, 95%CI: 0.02, 0.59, P = 0.036). Patients with postoperative PVR had longer duration of RD symptoms than those without (pooled WMD = 10.36, 95%CI: 2.29, 18.43, P = 0.012). Age, smoking, preoperative PVR, vitreous hemorrhage, aphakia or pseudophakia, macula off, extent of RD, and duration of RD symptoms were risk factors for postoperative PVR in patients undergoing RD surgery, which may help better identify high-risk patients, and provide timely interventions.
Sections du résumé
BACKGROUND
To comprehensively investigate risk factors for proliferative vitreoretinopathy (PVR) after retinal detachment (RD) surgery.
METHODS
PubMed, Embase, Cochrane Library, and Web of Science were systematically searched until May 22, 2023. Risk factors included demographic and disease-related risk factors. Odds ratios (ORs) and weighted mean differences (WMDs) were used as the effect sizes, and shown with 95% confidence intervals (CIs). Sensitivity analysis was conducted. The protocol was registered with PROSPERO (CRD42022378652).
RESULTS
Twenty-two studies of 13,875 subjects were included in this systematic review and meta-analysis. Increased age was associated with a higher risk of postoperative PVR (pooled WMD = 3.98, 95%CI: 0.21, 7.75, P = 0.038). Smokers had a higher risk of postoperative PVR than non-smokers (pooled OR = 5.07, 95%CI: 2.21-11.61, P<0.001). Presence of preoperative PVR was associated with a greater risk of postoperative PVR (pooled OR = 22.28, 95%CI: 2.54, 195.31, P = 0.005). Presence of vitreous hemorrhage was associated with a greater risk of postoperative PVR (pooled OR = 4.12, 95%CI: 1.62, 10.50, P = 0.003). Individuals with aphakia or pseudophakia had an increased risk of postoperative PVR in contrast to those without (pooled OR = 1.41, 95%CI: 1.02, 1.95, P = 0.040). The risk of postoperative PVR was higher among patients with macula off versus those with macula on (pooled OR = 1.85, 95%CI: 1.24, 2.74, P = 0.002). Extent of RD in patients with postoperative PVR was larger than that in patients without (pooled WMD = 0.31, 95%CI: 0.02, 0.59, P = 0.036). Patients with postoperative PVR had longer duration of RD symptoms than those without (pooled WMD = 10.36, 95%CI: 2.29, 18.43, P = 0.012).
CONCLUSION
Age, smoking, preoperative PVR, vitreous hemorrhage, aphakia or pseudophakia, macula off, extent of RD, and duration of RD symptoms were risk factors for postoperative PVR in patients undergoing RD surgery, which may help better identify high-risk patients, and provide timely interventions.
Identifiants
pubmed: 37903162
doi: 10.1371/journal.pone.0292698
pii: PONE-D-23-09520
pmc: PMC10615281
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0292698Informations de copyright
Copyright: © 2023 Xiang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Retina. 2021 Nov 1;41(11):2288-2295
pubmed: 34001820
Optometry. 2011 May;82(5):310-7
pubmed: 21524603
Optom Vis Sci. 2014 Jul;91(7):769-77
pubmed: 24927140
Acta Ophthalmol. 2018 Mar;96(2):192-196
pubmed: 29068530
Ophthalmologica. 1984;188(3):148-52
pubmed: 6538676
Int J Retina Vitreous. 2023 Feb 22;9(1):11
pubmed: 36814290
Clin Exp Optom. 2022 Nov 14;:1-7
pubmed: 36375137
Graefes Arch Clin Exp Ophthalmol. 1988;226(3):201-5
pubmed: 3402740
Am J Ophthalmol. 2004 Jun;137(6):1105-15
pubmed: 15183797
Ophthalmol Retina. 2020 Aug;4(8):823-828
pubmed: 32307330
Ophthalmologe. 2021 Jan;118(1):3-9
pubmed: 32666172
Acta Ophthalmol. 2017 Jun;95(4):e278-e283
pubmed: 27682827
Retina. 2019 Aug;39(8):1488-1495
pubmed: 29787465
Syst Rev. 2016 Jul 08;5(1):107
pubmed: 27391963
Sci Rep. 2021 Dec 14;11(1):23989
pubmed: 34907233
Int J Retina Vitreous. 2022 Sep 3;8(1):61
pubmed: 36057670
Eur J Ophthalmol. 2023 Nov;33(6):2285-2289
pubmed: 36987589
Eye (Lond). 2023 Apr;37(6):1114-1122
pubmed: 35473967
Arch Ophthalmol. 1989 Aug;107(8):1147-51
pubmed: 2757544
Front Immunol. 2018 Apr 09;9:586
pubmed: 29686666
Surv Ophthalmol. 2013 Jul-Aug;58(4):321-9
pubmed: 23642514
Graefes Arch Clin Exp Ophthalmol. 1996 Nov;234(11):677-82
pubmed: 8950587
Retina. 1994;14(5):417-24
pubmed: 7899716
Clin Ophthalmol. 2012;6:1325-33
pubmed: 22942638
Indian J Ophthalmol. 2023 Jan;71(1):28-38
pubmed: 36588205
PLoS One. 2022 Sep 1;17(9):e0271950
pubmed: 36048826
Ophthalmology. 2016 Mar;123(3):646-54
pubmed: 26686964
Doc Ophthalmol. 2000;100(1):39-42
pubmed: 11117409
Retina. 2012 Oct;32(9):1862-7
pubmed: 22466487
Sci Rep. 2020 Nov 11;10(1):19528
pubmed: 33177614
Ophthalmology. 2015 Jun;122(6):1257-61
pubmed: 25835263
Int J Ophthalmol. 2023 Feb 18;16(2):215-223
pubmed: 36816206
Curr Opin Ophthalmol. 2011 Nov;22(6):477-82
pubmed: 21897240
Retina. 2017 Jul;37(7):1229-1235
pubmed: 27787448
Invest Ophthalmol Vis Sci. 1999 Mar;40(3):705-12
pubmed: 10067974
Curr Opin Hematol. 2001 May;8(3):131-6
pubmed: 11303144
Curr Eye Res. 2005 Feb;30(2):147-53
pubmed: 15814473
Am J Ophthalmol. 2012 Aug;154(2):347-354.e2
pubmed: 22541653
Retina. 2021 May 1;41(5):947-956
pubmed: 32858667
J Fr Ophtalmol. 2014 Oct;37(8):653-9
pubmed: 24997865
Prog Retin Eye Res. 1998 Jan;17(1):77-98
pubmed: 9537796
Graefes Arch Clin Exp Ophthalmol. 1998 Jul;236(7):481-5
pubmed: 9672792